Clinical News
Informatics
Industry News
Medical, Legal, And Practice
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Neuroradiology: Page 44
Developmental venous anomalies can be overlooked on MRI
By
Rabia Mughal
Developmental venous anomalies may be the most frequently encountered cerebral vascular malformations, but they can often be overlooked on MRI findings, according to a new study from Turkey that offers some tips on identifying the conditions on MRI exams.
December 25, 2013
Study links gadolinium MR contrast to brain abnormalities
By
Wayne Forrest
Japanese researchers have found a connection between gadolinium-based MRI contrast and abnormalities in two regions of the brain, which could represent a reaction to gadolinium's toxicity, according to a study published on 17 December in
Radiology
.
December 22, 2013
7T MRA delves deeper into intracranial aneurysms
By
Wayne Forrest
CHICAGO - If and when it is ready for routine clinical use, 7-tesla time-of-flight MR angiography (MRA) will provide "superior assessment" of aneurysms and related vessel features, according to a study presented at RSNA 2013.
December 8, 2013
Superresolution ultrasound maps the brain
By
Jon Cartwright
Researchers have overcome an inability of ultrasound to map capillaries and other vessels in the brain by injecting micrometer-sized bubbles into the bloodstream. Although the technique has been demonstrated only on a model brain so far, it's a promising new way to map the brain's vascular networks.
November 28, 2013
PiB-PET shows more beta amyloid after traumatic brain injury
By
Wayne Forrest
British researchers are using PET imaging with the Pittsburgh Compound B (PiB) radiopharmaceutical to show -- for the first time -- increased beta-amyloid deposits in cortical gray matter and striatum regions following traumatic brain injury.
November 17, 2013
Piramal highlights florbetaben PET results
By
AuntMinnieEurope.com staff writers
Radiopharmaceutical firm Piramal Imaging said four studies of its florbetaben PET agent will be presented at the European Association of Nuclear Medicine congress in Lyon, France.
October 20, 2013
MRA helps detect risk from unruptured cerebral aneurysms
By
Wayne Forrest
MR angiography (MRA) using a 3D time-of-flight sequence could well be the most efficient technique for detecting unruptured cerebral aneurysms and determining if they pose a health risk, according to a study published in the October 15 issue of
Annals of Internal Medicine
.
October 16, 2013
Lancet
: Angiography busts theory of venous link to MS
By
Eric Barnes
Countering prior findings that cerebrospinal venous narrowing and multiple sclerosis (MS) go hand in hand, a study incorporating both x-ray venography and ultrasound found that venous narrowing is unrelated to MS. The new results were published online on 9 October in
Lancet
.
October 13, 2013
Brain stones: Between a rock and a hard place?
By
Philip Ward
Brain stones -- large solid intracranial calcifications -- are more common than previously thought, and while MRI sequences can be useful adjuncts, CT is now the mainstay in identifying and characterizing these intriguing items, Belgian researchers have asserted.
October 8, 2013
Functional MRI studies scoop top awards at ESMRMB
By
Philip Ward
Researchers from the U.K. and France collected prestigious prizes at the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) meeting in Toulouse, France, for their investigations into resting state functional MRI.
October 6, 2013
Jury's still out on clinical impact of resting-state fMRI studies
By
Frances Rylands-Monk
For radiologists, performing and evaluating resting-state functional MRI (fMRI) examinations will require education, availability of specific data treatment programs, and a sound understanding of the functioning of the brain in health and disease in order to make a correct decision about the patient's condition.
October 6, 2013
GE highlights DaTScan dementia data
By
AuntMinnieEurope.com staff writers
GE Healthcare is highlighting a trial that evaluated its DaTScan SPECT imaging agent to diagnose patients with dementia with Lewy bodies.
September 26, 2013
Previous Page
Page 44 of 59
Next Page